ES2113109T3 - Procedimiento para el rastreo de sustancias con efecto modulador sobre una via de transmision de señales dependiente de un receptor de interleuquina 5. - Google Patents

Procedimiento para el rastreo de sustancias con efecto modulador sobre una via de transmision de señales dependiente de un receptor de interleuquina 5.

Info

Publication number
ES2113109T3
ES2113109T3 ES94918807T ES94918807T ES2113109T3 ES 2113109 T3 ES2113109 T3 ES 2113109T3 ES 94918807 T ES94918807 T ES 94918807T ES 94918807 T ES94918807 T ES 94918807T ES 2113109 T3 ES2113109 T3 ES 2113109T3
Authority
ES
Spain
Prior art keywords
interleukin
signal transmission
transmission way
receiver
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94918807T
Other languages
English (en)
Inventor
Armin Peter Czernilofsky
Ulrike Weyer
Ian G Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2113109T3 publication Critical patent/ES2113109T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA SUSTANCIAS DE APANTALLADO DISPONIENDO DE UN EFECTO DE MODULACION SOBRE RECEPTOR INTERLEUQUINA-5 DEPENDIENTE DE LA VIA DE TRANSMISION DE SEÑAL EN CELULAS DE MAMIFEROS. LAS SUSTANCIAS DE PRUEBA SE APLICAN SOBRE CELULAS QUE EXPRESAN EL RECEPTOR INTERLEUQUINA-5 FUNCIONAL Y SON TRANSFORMADAS CON UN RECOMBINANTE DNA CONTENIENDO UN GEN DE INFORMACION Y UNA SECUENCIA REGULATORIA LIGADA FUNCIONALMENTE QUE ES SENSITIVA A CAMBIO EN LA CONCENTRACION DE UNA SUSTANCIA DE MENSAJES SECUNDARIA DEL RECEPTOR INTERLEUQUINA-5 DEPENDIENTE DE LA VIA DE TRANSMISION DE SEÑAL. LAS SUSTANCIAS ESPECIFICAS DE LA VIA DE TRANSMISION DE SEÑAL DEPENDIENTE DEL RECEPTOR INTERLEUQUINA-5 Y CON EFECTO FARMACOLOGICO POTENCIAL PUEDEN SER IDENTIFICADAS MEDIANTE ESTE PROCESO.
ES94918807T 1993-05-27 1994-05-27 Procedimiento para el rastreo de sustancias con efecto modulador sobre una via de transmision de señales dependiente de un receptor de interleuquina 5. Expired - Lifetime ES2113109T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4317577A DE4317577A1 (de) 1993-05-27 1993-05-27 Verfahren zum Screenen von Substanzen mit modulierender Wirkung auf einen Interleukin-5-Rezeptor-abhängigen zellulären Signalübertragungsweg

Publications (1)

Publication Number Publication Date
ES2113109T3 true ES2113109T3 (es) 1998-04-16

Family

ID=6488996

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94918807T Expired - Lifetime ES2113109T3 (es) 1993-05-27 1994-05-27 Procedimiento para el rastreo de sustancias con efecto modulador sobre una via de transmision de señales dependiente de un receptor de interleuquina 5.

Country Status (17)

Country Link
US (1) US5922549A (es)
EP (1) EP0701628B1 (es)
JP (1) JPH08510643A (es)
KR (1) KR100318188B1 (es)
CN (1) CN1125467A (es)
AT (1) ATE162555T1 (es)
AU (1) AU691816B2 (es)
CA (1) CA2163549A1 (es)
DE (2) DE4317577A1 (es)
DK (1) DK0701628T3 (es)
ES (1) ES2113109T3 (es)
FI (1) FI111016B (es)
HU (1) HU220345B (es)
NO (1) NO316027B1 (es)
NZ (1) NZ291131A (es)
RU (1) RU2139936C1 (es)
WO (1) WO1994028170A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405350D0 (en) * 1994-03-18 1994-05-04 Sandoz Ltd Organic compounds
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
RU2181773C2 (ru) * 2000-03-16 2002-04-27 Научно-исследовательский институт вирусологии им. Д.И. Ивановского РАМН Способ определения цитокинового статуса человека на генетическом уровне
WO2002028168A1 (en) * 2000-10-03 2002-04-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education High efficiency regulatable gene expression system
RU2215292C2 (ru) * 2000-12-28 2003-10-27 Общество С Ограниченной Ответственностью "Ферон" Способ выбора терапии при герпесе
WO2004042007A2 (en) * 2002-10-30 2004-05-21 University Of Iowa Research Foundation Somatic cell gene targeting vectors and methods of use thereof
US20040209246A1 (en) * 2003-04-15 2004-10-21 Agouron Pharmaceuticals, Inc. Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
US20050112551A1 (en) * 2003-11-24 2005-05-26 Agouron Pharmaceuticals, Inc. Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
AU1469292A (en) * 1991-01-18 1992-08-27 Oncogene Science, Inc. Methods of transcriptionally modulating expression of growth factor genes and growth factor receptor genes
WO1993007294A1 (en) * 1991-10-01 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Service A method of identifying ligands and antagonists of ligands

Also Published As

Publication number Publication date
FI955700A0 (fi) 1995-11-27
FI111016B (fi) 2003-05-15
AU691816B2 (en) 1998-05-28
HUT73742A (en) 1996-09-30
KR960702532A (ko) 1996-04-27
AU6997794A (en) 1994-12-20
US5922549A (en) 1999-07-13
DE59405120D1 (de) 1998-02-26
CN1125467A (zh) 1996-06-26
WO1994028170A1 (de) 1994-12-08
NO954781D0 (no) 1995-11-24
EP0701628A1 (de) 1996-03-20
KR100318188B1 (ko) 2002-06-20
HU220345B (hu) 2001-12-28
FI955700L (fi) 1995-11-27
NZ291131A (en) 1996-10-28
NO954781L (no) 1996-01-23
CA2163549A1 (en) 1994-12-08
DE4317577A1 (de) 1994-12-01
DK0701628T3 (da) 1998-09-21
ATE162555T1 (de) 1998-02-15
JPH08510643A (ja) 1996-11-12
NO316027B1 (no) 2003-12-01
EP0701628B1 (de) 1998-01-21
RU2139936C1 (ru) 1999-10-20
HU9503363D0 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
ES2114951T3 (es) Procedimiento para el rastreo de sustancias con efecto modulador sobre una via de transmision de señales celular, dependiente del receptor.
ES2113109T3 (es) Procedimiento para el rastreo de sustancias con efecto modulador sobre una via de transmision de señales dependiente de un receptor de interleuquina 5.
EP0348235A3 (en) Optical fiber evaluation methods and system using Brillouin amplification
ES2044835T5 (es) Deteccion de microbios en una muestra.
ES2067965T3 (es) Composicion de adhesivo acrilico y sistema iniciador organoboro.
FR2650416B1 (fr) Systeme de transmission d'informations, objet portatif et lecteur utilisables dans un tel systeme
DE69527850D1 (de) Bioluminiscente lyophilisierte bakterien-reagenz zur giftstoff nachweit
FI972457A0 (fi) FAS/APO1-reseptorien toiminnan modulaattorit
DE59107549D1 (de) Verwendung von Peptidpaaren mit extrem hoher spezifischer Affinität zueinander im Bereich der in vitro Diagnostik
ATE101286T1 (de) Anzeigevorrichtung.
ATE304595T1 (de) Lichtproduzierender biosensor
ATE175498T1 (de) Sensor für optische prüfung
DE3867541D1 (de) Optisch aktives polymer und zusammensetzung von fluessigem kristall, die dieses enthaelt.
ATE41259T1 (de) Geraet zur wiedergabe von informationen auf einem optisch lesbaren informationstraeger.
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
ATE49659T1 (de) Probe zur identifizierung von hla d.
ATE250084T1 (de) Typ i prokollagen aminoterminales propeptid, dessen antikörper und testverfahren unter verwendung davon
ATE144791T1 (de) Innerhalb des alpha-locus gelegenes t-zell- rezeptor-gen und dna-konstruktionen
DE69316388D1 (de) CRF Bindungsproteine
FI863953A0 (fi) Belysning av en vaetskekristalldisplay.
DE69632826D1 (de) Nukleinsaeure erkennung von hepatitis gb virus
AU6519790A (en) Method and device for writing and reading information from a support based on ferroelectric material
FR2417848A1 (fr) Methode d'effacement d'un panneau a plasma et systemes de visualisation par panneau a plasma utilisant cette methode
DE69333007D1 (de) Alkalische phosphatase-enzyme mit verbesserter spezifischer aktivität in der verwendung als indikator-reagenzien
GB1350266A (en) Electro-optical modulation device

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 701628

Country of ref document: ES